(Q33796180)

29 July 2017

Multiple biomarkers predict disease severity, progression and mortality in COPD. (English)

1 reference

chronic obstructive pulmonary disease

29 July 2017

0 references

1 reference

6

Ruth Tal-Singer

1 reference

29 July 2017

Rachel L Zemans

1

1 reference

29 July 2017

Sean Jacobson

2

1 reference

29 July 2017

Jason Keene

3

1 reference

29 July 2017

Katerina Kechris

4

1 reference

29 July 2017

Bruce E Miller

5

1 reference

29 July 2017

Russell P Bowler

7

1 reference

29 July 2017

13 June 2017

1 reference

29 July 2017

1 reference

29 July 2017

18

1 reference

29 July 2017

1

1 reference

29 July 2017

117

1 reference

https://scigraph.springernature.com/pub.10.1186/s12931-017-0597-7

29 July 2017

0 references

cites work

Development and Validation of a Protein-Based Risk Score for Cardiovascular Outcomes Among Patients With Stable Coronary Heart Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5470282

Plasma Fibrinogen as a Biomarker for Mortality and Hospitalized Exacerbations in People with COPD.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5470282

The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5470282

Soluble receptor for advanced glycation end-products and progression of airway disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5470282

Club cell protein 16 and disease progression in chronic obstructive pulmonary disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5470282

Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5470282

Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5470282

Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5470282

Genetic epidemiology of COPD (COPDGene) study design

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5470282

C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5470282

C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5470282

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5470282

Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical Implementation.

4 July 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0597-7

Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0597-7

Changes in forced expiratory volume in 1 second over time in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0597-7

The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0597-7

Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0597-7

Fibrinogen, COPD and mortality in a nationally representative U.S. cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0597-7

Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0597-7

Systemic soluble receptor for advanced glycation endproducts is a biomarker of emphysema and associated with AGER genetic variants in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0597-7

Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0597-7

The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0597-7

Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0597-7

Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0597-7

The prediction of small airway dimensions using computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0597-7

Plasma pro-surfactant protein B and lung function decline in smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0597-7

Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5470282

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5470282

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

30 October 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0597-7

Inflammatory Biomarkers Improve Clinical Prediction of Mortality in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0597-7

Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0597-7

Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12931-017-0597-7

Elevated Plasma Fibrinogen Associated with Reduced Pulmonary Function and Increased Risk of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28610627

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/S12931-017-0597-7

1 reference

Dimensions Publication ID

29 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/s12931-017-0597-7

9 September 2019

1 reference

29 July 2017

1 reference